We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

CERVICAL SPONDYLOSIS TREATMENT MARKET ANALYSIS

Cervical Spondylosis Treatment Market, By Type of Treatment (Medications (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, Muscle relaxants, Antidepressants and Others) and Surgery), By Route of Administration (Oral, Injection, Topical, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

  • Published In : Nov 2023
  • Code : CMI5710
  • Pages :165
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

Regional Analysis

Cervical Spondylosis Treatment Market Regional Insights

  • In 2023, North America dominated the cervical spondylosis treatment market in terms of revenue share, followed by Europe and Asia Pacific. The growth in the North America region is attributed to factors such as the high prevalence of cervical spondylosis, the availability of advanced healthcare infrastructure, and the presence of key market players. It is estimated to hold around 36.7% of the global market share. For instance, according to the StatPearls journal, in May 2023, cervical spondylosis was considered a natural process of aging with a 95% prevalence by the age of 65 years in the U.S. Most people remain asymptomatic but can suffer from axial neck pain, as well as with cervical radiculopathy and/or cervical myelopathy.
  • Europe is also a significant market for cervical spondylosis treatment, owing to the high prevalence of cervical spondylosis in the region and the availability of advanced healthcare infrastructure. The growing geriatric population in the region is also driving the demand for cervical spondylosis treatment. Europe is estimated to hold approximately 30.7% of the global market share.
  • Asia Pacific is expected to witness significant growth in the cervical spondylosis treatment market during the forecast period owing to factors such as the increasing prevalence of cervical spondylosis, the growing geriatric population, and the development of healthcare infrastructure in emerging economies. The market in the Asia Pacific region is estimated to capture around 25.2% of the global market share.

Figure 1. Global Cervical Spondylosis Treatment Market Share (%), By Region, 2023

request-sample

Geographies covered

  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East:  GCC, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.